Semaglutide

Description

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed to mimic the activity of the naturally occurring incretin hormone GLP-1. Its extended duration of action has made it one of the most extensively studied peptides in metabolic research, particularly in investigations involving glucose homeostasis, appetite regulation, and body weight.

Researchers have investigated Semaglutide in numerous preclinical and clinical studies to better understand the physiological effects of GLP-1 receptor activation. Scientific research continues to explore its influence on insulin secretion, glucagon regulation, gastric emptying, satiety signalling, and energy metabolism, making it a valuable tool in endocrinology and metabolic science.

Areas of Scientific Interest

• Research has investigated Semaglutide for its activation of GLP-1 receptors involved in glucose regulation and metabolic homeostasis.
• Clinical studies have examined its effects on appetite regulation, satiety signalling, gastric emptying, and body weight through incretin-mediated pathways.
• Experimental research has explored the role of GLP-1 receptor agonists in insulin secretion, glucagon regulation, and energy balance.
• Ongoing investigations continue to evaluate GLP-1 signalling in cardiovascular physiology, neurobiology, and metabolic disease research.

Product Features

• High-purity lyophilised peptide
• Contains 5mg Semaglutide
• Manufactured for laboratory and scientific research
• Quality tested for identity and purity
• Securely packaged to help maintain product integrity

References

• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
• Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 2016.
• Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 2015.